Joshua M. Eizen - Chief Operating Officer and Chief Legal Officer at AN2 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer and Chief Legal Officer
Stock Symbol
ANTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Joshua M. Eizen since 12/22/2023

Holdings reported by Joshua M. Eizen for AN2 Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 126K $131K $1.04 Nov 4, 2024 Direct
Stock Option (right to buy) 63K Nov 4, 2024 Direct Common Stock

Transactions reported by Joshua M. Eizen for AN2 Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.